Clinical trial evaluating the safety, neutralizing capacity and the lowest effective dose for antivenom treatment of multiple Africanized bees stings Apis mellifera
Phase 1
- Conditions
- Stings, insect BitesC25.723.127.071
- Registration Number
- RBR-3fthf8
- Lead Sponsor
- Faculdade de Medicina de Botucatu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Be aged over 18 and under 60 years of both sexes; having a diagnosis of crash with bees Apis; have the consent of the patient or family to receive antivenom.
Exclusion Criteria
Have had frequent contact with products of horse; have had previous adverse reaction to receiving the antivenom; to be pregnant; be with chronic disease, including congenital and acquired immunodeficiencies; introduce diseases that the combined use contraindication antihistamines, corticosteroids and potent analgesics, including allergic reaction.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method